Immunotherapy Converts Non-immunogenic Pancreatic Tumors into Immunogenic Foci of Immune Regulation

Pancreatic ductal adenocarcinoma (PDAC) is considered a “non-Immunogenic” neoplasm. Single agent immunotherapies have failed to demonstrate significant clinical activity in PDAC and other “non-immunogenic” tumors, in part due to a complex tumor microenvironment (TME) that provides a formidable barri...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Lutz, Eric R., Wu, Annie A., Bigelow, Elaine, Sharma, Rajni, Mo, Guanglan, Soares, Kevin, Solt, Sara, Dorman, Alvin, Wamwea, Anthony, Yager, Allison, Laheru, Daniel, Wolfgang, Christopher L., Wang, Jiang, Hruban, Ralph H., Anders, Robert A., Jaffee, Elizabeth M., Zheng, Lei
פורמט: Artigo
שפה:Inglês
יצא לאור: 2014
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4082460/
https://ncbi.nlm.nih.gov/pubmed/24942756
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-14-0027
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים